Additional file 1 of Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
Additional file 1. Supplementary Information: Participating centers, neurologists and listed in order of their respective contributions in number of patients.
| Verfasser: | |
|---|---|
| Dokumenttyp: | Text |
| Erscheinungsdatum: | 2021 |
| Schlagwörter: | Medicine / Neuroscience / Pharmacology / Immunology / Cancer / Science Policy / Chemical Sciences not elsewhere classified / Multiple sclerosis spasticity / Observational study / Cannabinoid oromucosal spray / Treatment effect / Treatment satisfaction |
| Sprache: | unknown |
| Permalink: | https://search.fid-benelux.de/Record/base-28875013 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://doi.org/10.6084/m9.figshare.14826167.v1 |
